• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三维适形放疗和调强适形放疗对颈段和胸上段食管癌患者甲状腺功能的影响及临床疗效比较

Influence of 3D-CRT and conformal IMRT on thyroid function of patients with cervical and upper thoracic esophageal cancer and comparison of clinical efficacy.

作者信息

Chen Fei, Li Jun, Ai Nian, Zhang Huaping, Li Jun, Zhu Yingying

机构信息

Department of Oncology, Xiaogan Hospital Affiliated to Wuhan University of Science and Technology, Xiaogan, Hubei 432000, P.R. China.

Department of Oncology, The Central Hospital of Xiaogan, Xiaogan, Hubei 432000, P.R. China.

出版信息

Oncol Lett. 2019 Mar;17(3):3432-3438. doi: 10.3892/ol.2019.9989. Epub 2019 Jan 29.

DOI:10.3892/ol.2019.9989
PMID:30867781
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6396116/
Abstract

Clinical efficacy in patients with cervical and upper thoracic esophageal cancer was compared between three-dimensional conformal radiotherapy (3D-CRT) and conformal intensity-modulated radiotherapy (IMRT). Medical data of 120 esophageal cancer patients undergoing RT in the Radiology Department in Xiaogan Hospital Affiliated to Wuhan University of Science and Technology (Xiaogan, China) from March 2015 to March 2018 were retrospectively analyzed. Patients were divided into 3D-CRT group (treated with 3D-CRT, n=60) and IMRT group (treated with IMRT, n=60). The target conformal index (CI), PTV maximum dose (D), PTV D and PTV D in both groups were observed. Changes in double-lung V5, double-lung V20, double-lung V30 and spinal cord D in both groups were also observed. The serum free triiodothyronine (FT3), free tetraiodothyronine (FT4) and thyroid-stimulating hormone (TSH) concentrations were detected via chemiluminescence assay. Moreover, the short-term efficacy and radiation injury were observed. CI in IMRT group was significantly higher than that in 3D-CRT group (P<0.001). The organ-at-risk dose parameter V20 in IMRT group was obviously lower than that in 3D-CRT group (P<0.001). Serum FT3 and FT4 concentrations in both groups before RT were significantly higher than those after RT (P<0.05), but the TSH concentration was significantly lower than that after RT (P<0.05). Serum FT3 and FT4 concentrations in IMRT group after RT were obviously higher than those in 3D-CRT group (P<0.05). The incidence rates of radiation esophagitis and radiation pneumonitis in IMRT group were remarkably lower than those in 3D-CRT group (P<0.05). IMRT can reduce the double-lung V20 in patients, improve the target conformal degree, better protect the normal tissues, cause less damage to thyroid function, and reduce radiation injury during and after RT of esophageal cancer.

摘要

比较三维适形放疗(3D-CRT)与调强适形放疗(IMRT)治疗颈段和胸上段食管癌患者的临床疗效。回顾性分析2015年3月至2018年3月在武汉大学附属孝感医院放射科接受放疗的120例食管癌患者的医学资料。将患者分为3D-CRT组(接受3D-CRT治疗,n=60)和IMRT组(接受IMRT治疗,n=60)。观察两组的靶区适形指数(CI)、计划靶区(PTV)最大剂量(D)、PTV平均剂量(Dmean)和PTV最小剂量(Dmin)。同时观察两组双肺V5、双肺V20、双肺V30和脊髓D的变化。采用化学发光法检测血清游离三碘甲状腺原氨酸(FT3)、游离甲状腺素(FT4)和促甲状腺激素(TSH)浓度。此外,观察短期疗效和放射性损伤。IMRT组的CI明显高于3D-CRT组(P<0.001)。IMRT组的危及器官剂量参数V20明显低于3D-CRT组(P<0.001)。两组放疗前血清FT3和FT4浓度均明显高于放疗后(P<0.05),但TSH浓度明显低于放疗后(P<0.05)。IMRT组放疗后血清FT3和FT4浓度明显高于3D-CRT组(P<0.05)。IMRT组放射性食管炎和放射性肺炎的发生率明显低于3D-CRT组(P<0.05)。IMRT可降低患者双肺V20,提高靶区适形度,更好地保护正常组织,对甲状腺功能损伤较小,并减少食管癌放疗期间及放疗后的放射性损伤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd15/6396116/24d0ed0e9b16/ol-17-03-3432-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd15/6396116/a361ae7a3cd2/ol-17-03-3432-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd15/6396116/d8a9353f83f8/ol-17-03-3432-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd15/6396116/24d0ed0e9b16/ol-17-03-3432-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd15/6396116/a361ae7a3cd2/ol-17-03-3432-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd15/6396116/d8a9353f83f8/ol-17-03-3432-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd15/6396116/24d0ed0e9b16/ol-17-03-3432-g02.jpg

相似文献

1
Influence of 3D-CRT and conformal IMRT on thyroid function of patients with cervical and upper thoracic esophageal cancer and comparison of clinical efficacy.三维适形放疗和调强适形放疗对颈段和胸上段食管癌患者甲状腺功能的影响及临床疗效比较
Oncol Lett. 2019 Mar;17(3):3432-3438. doi: 10.3892/ol.2019.9989. Epub 2019 Jan 29.
2
Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation.不可切除的非小细胞肺癌治疗中降低毒性和增加剂量的潜力:调强放射治疗(IMRT)、三维适形放疗和选择性淋巴结照射的比较
Int J Radiat Oncol Biol Phys. 2003 Nov 1;57(3):875-90. doi: 10.1016/s0360-3016(03)00743-0.
3
[Clinical study of intensity modulated radiotherapy and three-dimensional conformal radiotherapy with three-dimensional brachytherapy and concurrent chemotherapy for patients with advanced cervical cancer].[调强放疗与三维适形放疗联合三维近距离放疗及同步化疗治疗晚期宫颈癌的临床研究]
Zhonghua Fu Chan Ke Za Zhi. 2017 Oct 25;52(10):679-686. doi: 10.3760/cma.j.issn.0529-567X.2017.10.007.
4
[Dose distributions of proton beam therapy for hepatocellular carcinoma: a comparative study of treatment planning with 3D-conformal radiation therapy or intensity-modulated radiation therapy].肝细胞癌质子束治疗的剂量分布:与三维适形放射治疗或调强放射治疗的治疗计划比较研究
Zhonghua Yi Xue Za Zhi. 2009 Dec 8;89(45):3201-6.
5
Minimising contralateral breast dose in post-mastectomy intensity-modulated radiotherapy by incorporating conformal electron irradiation.通过采用适形电子照射来降低乳腺癌术后调强放疗中对侧乳房的剂量。
Radiother Oncol. 2010 Feb;94(2):235-40. doi: 10.1016/j.radonc.2009.12.015. Epub 2010 Jan 18.
6
Dosimetric comparison between modulated arc therapy and static intensity modulated radiotherapy in thoracic esophageal cancer: a single institutional experience.胸段食管癌调强弧形放疗与静态调强放疗的剂量学比较:单机构经验
Radiat Oncol J. 2018 Mar;36(1):63-70. doi: 10.3857/roj.2017.00241. Epub 2017 Dec 23.
7
3D-conformal RT, fixed-field IMRT and RapidArc, which one is better for esophageal carcinoma treated with elective nodal irradiation.三维适形放疗、固定野调强放疗和 RapidArc 放疗,对于选择性淋巴结照射治疗食管癌,哪一种更好。
Technol Cancer Res Treat. 2011 Oct;10(5):487-94. doi: 10.7785/tcrt.2012.500225.
8
[Dosimetric comparison between intensity-modulated radiotherapy and conformal radiotherapy for upper thoracic esophageal carcinoma].[胸段上段食管癌调强放疗与适形放疗的剂量学比较]
Ai Zheng. 2009 Nov;28(11):1127-31. doi: 10.5732/cjc.008.10839.
9
Comparison of nodal irradiation dose using radiotherapy for patients with thoracic esophageal cancer.胸段食管癌患者放疗时淋巴结照射剂量的比较
Oncol Lett. 2020 Jan;19(1):1042-1050. doi: 10.3892/ol.2019.11178. Epub 2019 Dec 3.
10
Comparison of inverse-planned three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for non-small-cell lung cancer.非小细胞肺癌逆向计划三维适形放疗与调强放疗的比较。
Int J Radiat Oncol Biol Phys. 2007 Mar 1;67(3):735-41. doi: 10.1016/j.ijrobp.2006.09.047. Epub 2006 Dec 21.

引用本文的文献

1
Dose escalation in radical radio(chemo)therapy for cervical and upper thoracic esophageal cancer with 3DCRT/IMRT (ChC&UES): a multicenter retrospective study.三维适形放疗/调强放疗根治性放化疗治疗颈胸上段食管癌的剂量递增:一项多中心回顾性研究。
Radiat Oncol. 2024 Sep 27;19(1):126. doi: 10.1186/s13014-024-02521-7.
2
Definitive chemo-radiotherapy in cervical oesophageal cancer: a comprehensive review of literature.颈段食管癌的确定性放化疗:文献综述
Rep Pract Oncol Radiother. 2024 Jul 22;29(3):391-408. doi: 10.5603/rpor.100777. eCollection 2024.
3
Incidence of hypothyroidism after treatment for breast cancer: A Korean population-based study.

本文引用的文献

1
Technical feasibility and oncologic safety of diagnostic endoscopic resection for superficial esophageal cancer.诊断性内镜切除治疗早期食管癌的技术可行性和肿瘤安全性。
Gastrointest Endosc. 2018 Sep;88(3):456-465. doi: 10.1016/j.gie.2018.04.2361. Epub 2018 May 8.
2
[Dosimetric analysis of volumetric modulated arc therapy and intensity modulated radiotherapy for patients undergone breast-conserving operation].[保乳手术后患者容积调强弧形放疗和调强放疗的剂量学分析]
Beijing Da Xue Xue Bao Yi Xue Ban. 2018 Feb 18;50(1):188-192.
3
NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients.
乳腺癌治疗后甲状腺功能减退症的发病率:一项基于韩国人群的研究。
PLoS One. 2022 Jun 16;17(6):e0269893. doi: 10.1371/journal.pone.0269893. eCollection 2022.
4
Association of volumetric-modulated arc therapy with radiation pneumonitis in thoracic esophageal cancer.容积旋转调强弧形治疗与胸段食管癌放射性肺炎的关系。
J Radiat Res. 2022 Jul 19;63(4):646-656. doi: 10.1093/jrr/rrac021.
5
Definitive Chemoradiotherapy with Docetaxel, Cisplatin, and 5-Fluorouracil for Advanced Cervical Esophageal Cancer: A Medium-Term Outcome.多西他赛、顺铂和氟尿嘧啶联合根治性放化疗治疗晚期颈段食管癌:中期疗效。
Asian Pac J Cancer Prev. 2022 Feb 1;23(2):495-499. doi: 10.31557/APJCP.2022.23.2.495.
NRG 肿瘤学 RTOG 9006:一项 III 期随机临床试验,比较超分割放疗 (RT) 和 BCNU 与标准 RT 和 BCNU 治疗恶性胶质瘤患者的效果。
J Neurooncol. 2018 Mar;137(1):39-47. doi: 10.1007/s11060-017-2558-x. Epub 2018 Feb 5.
4
Late radiation-associated dysphagia in head and neck cancer patients: evidence, research and management.头颈部癌症患者的晚期放射性吞咽困难:证据、研究与管理。
Oral Oncol. 2018 Feb;77:125-130. doi: 10.1016/j.oraloncology.2017.12.021. Epub 2018 Jan 4.
5
Intensity-modulated radiotherapy combined with paclitaxel and platinum treatment regimens in locally advanced esophageal squamous cell carcinoma.调强放疗联合紫杉醇和铂类药物治疗局部晚期食管鳞癌。
Clin Transl Oncol. 2018 Mar;20(3):411-419. doi: 10.1007/s12094-017-1734-y. Epub 2017 Aug 4.
6
Comparison of IMRT versus 3D-CRT in the treatment of esophagus cancer: A systematic review and meta-analysis.调强放射治疗(IMRT)与三维适形放射治疗(3D-CRT)在食管癌治疗中的比较:一项系统评价和荟萃分析
Medicine (Baltimore). 2017 Aug;96(31):e7685. doi: 10.1097/MD.0000000000007685.
7
Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer: The NRG Oncology RTOG 0436 Phase 3 Randomized Clinical Trial.厄洛替尼联合紫杉醇、顺铂和放疗治疗食管癌患者的效果:NRG 肿瘤学 RTOG 0436 期随机临床试验。
JAMA Oncol. 2017 Nov 1;3(11):1520-1528. doi: 10.1001/jamaoncol.2017.1598.
8
Effect of Midtreatment PET/CT-Adapted Radiation Therapy With Concurrent Chemotherapy in Patients With Locally Advanced Non-Small-Cell Lung Cancer: A Phase 2 Clinical Trial.局部晚期非小细胞肺癌患者中治疗中期 PET/CT 指导的放化疗的效果:一项 2 期临床试验。
JAMA Oncol. 2017 Oct 1;3(10):1358-1365. doi: 10.1001/jamaoncol.2017.0982.
9
Pulmonary Function Changes After Radiotherapy for Lung or Esophageal Cancer: A Systematic Review Focusing on Dose-Volume Parameters.放疗治疗肺癌或食管癌后肺功能的变化:一项侧重于剂量-体积参数的系统评价。
Oncologist. 2017 Oct;22(10):1257-1264. doi: 10.1634/theoncologist.2016-0324. Epub 2017 May 26.
10
Long Noncoding RNAs in the Pathogenesis of Barrett's Esophagus and Esophageal Carcinoma.长链非编码RNA在巴雷特食管和食管癌发病机制中的作用
Gastroenterology. 2017 Jul;153(1):27-34. doi: 10.1053/j.gastro.2017.04.046. Epub 2017 May 18.